Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

nhibitors; and the enabling capabilities of Cytokinetics biological focus. Such statements are based on management s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, that GSK or the NCI may decide to postpone or discontinue development efforts for GSK-923295 or ispinesib, respectively; that there may be difficulties or delays potential difficulties or delays in the development, testing, regulatory approval, production and marketing of Cytokinetics drug candidates that could slow or prevent clinical development, product approval or market acceptance, including risks that current and past results of clinical trials or preclinical studies may not be indicative of future clinical trials results, patient enrollment for clinical trials may be difficult or delayed, Cytokinetics drug candidates may have unexpected adverse side effects or inadequate therapeutic efficacy, and Cytokinetics may not be able to obtain and maintain patent or trade secret protection for its intellectual property; that Cytokinetics may incur unanticipated research and development and other costs or be unable to obtain additional financing if necessary; and that standards of care may change or others may introduce products or alternative therapies for the treatment of indications which Cytokinetics drug candidates and potential drug candidates currently or potentially target. For further information regarding these and other risks related to Cytokinetics business, investors should consult Cytokinetics filings with the Securities and Exchange Commission.


'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:3/31/2015)... , March 31, 2015  Frequentz Inc., a global ... a white paper to help the pharmaceutical industry understand ... Supply Chain Security Act (DSCSA). The white paper, "From ... the GS1 EPCIS Standard(s) and Implementation Plan ... the product tracing requirements that need to occur between ...
(Date:3/31/2015)... RESEARCH TRIANGLE PARK, N.C. , March 31, 2015 /PRNewswire/ ... Neeman International, will be attending the World Orphan Drug Congress ... India,s regulatory approval process and orphan drugs ... Advisory Board (DTAB) has recommended to the Ministry of Health ... a well-regulated country, marketing authorization can be obtained in ...
(Date:3/31/2015)... March 31, 2015  On May 2, 2015 ... in Santa Monica, CA ... Therapies for Malignant Pleural Mesothelioma (MPM), a rare ... asbestos and commonly affects the lining of the ... UCLA and the Pacific Mesothelioma Center (PMC). ...
Breaking Medicine Technology:Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4
... March 2, 2011 Warner Chilcott plc (Nasdaq: ... subsidiaries are seeking to refinance the Company,s existing credit ... (the "Existing Credit Agreement"), by entering into a new ... refinancing is expected to have the effect of extending ...
... take non-steroidal anti-inflammatory drugs three times a day for more ... erectile dysfunction compared to men who do not take those ... in The Journal of Urology . ... this observational study used electronic health records, an automated pharmacy ...
Cached Medicine Technology:Warner Chilcott Seeks to Refinance its Existing Credit Agreement 2Warner Chilcott Seeks to Refinance its Existing Credit Agreement 3Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 2Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 3
(Date:3/31/2015)... National (PRWEB) April 01, 2015 Every ... the S.A.D. (standard American diet) contains things banned in ... illness sky rockets every year. AlignLife Chiropractic & Natural ... patients but also their communities they can reduce the ... Throughout the year each AlignLife clinic offers workshops at ...
(Date:3/31/2015)... March 31, 2015 As the demand ... is pledging to have a mobile-friendly website online sometime ... part of Chunk Fitness’ continued commitment to bring the ... user base. All of the same great fitness information ... will be substantially easier to read while browsing on ...
(Date:3/31/2015)... Cosmetic Town, one of the most ... enduring adding news to its site while it redesigns ... plastic surgery and cosmetic medicine better use and navigate ... sections, the Cosmetic Town community is tingling at its ... Town site navigation, News and Blog section, will feature ...
(Date:3/31/2015)... In conjunction with the Asbestos ... the Mesothelioma Applied Research Foundation (Meso Foundation) announced ... complement its existing work in mesothelioma research, education, ... the Meso Foundation’s mission, we want to eliminate ... to asbestos, including mesothelioma,” said the Meso Foundation’s ...
(Date:3/31/2015)... In honor of National Disability Month, ... buying from a NMEDA QAP certified dealer. , ... nonprofit organization that provides consumer guidance and ensures ... of mobility equipment. The organization’s Quality Assurance Program ... adhere to the highest quality safety and customer ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3Health News:Advanced Driving Systems Celebrates National Disability Month 2
... with several aspects of physical and mental health by significantly ... been found// from recent studies that a strained relationship between ... process. This observation is believed to be due to a ... play a major role in wound healing) in the blood. ...
... citizens of Scotland to give up smoking on a voluntary basis. ... less trouble for the Government// that hopes to impose a public ... people who call up the smoking help line has infact increased ... is much more promising compared to the figures in 2003 where ...
... Bhopal gas leak tragedy was on Saturday 30 doctors of ... ,The doctors wanted a pay hike. The hospital gets around ... a trust, the BMHRC was set up as a super ... gas victims, it also treats private patients., ,The Essential ...
... to fund $142 million for cancer research facility in ... informed by its Premier Dalton McGuinty. The new research ... research activities in Ontario. The network will consist of ... they would discuss and work as a team in ...
... hormone injections (Leptin) taken twice daily by dieters help to maintain ... was headed by Dr Michael Rosenbaum of the Columbia University College ... light on the complex pathway that regulates metabolism and deposit fat. ... is to maintain the weight. ,A ...
... Men acquitted of a rape charge as he was suffering from ... is going to have her case against him in Canadian Supreme ... woman after a party when they were both in a drunken ... he was not aware or could remember of the act. Parasomnia ...
Cached Medicine News:Health News:Wound Healing Found To Be Slower In Couples Who Fight Often 2Health News:Leptin Injections Maintain Loss In Body Weight 2
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: